Exact Mass: 541.3084633999999

LysoPC(20:5)

(2-{[(2R)-2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium

LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position. The eicosapentaenoic acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)), in particular, consists of one chain of eicosapentaenoic acid at the C-1 position. The eicosapentaenoic acid moiety is derived from fish oils, liver and kidney. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.

1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide

N-[(6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl]-6-[2-(4-methylpiperazin-1-yl)pyridin-4-yl]-1-(propan-2-yl)-1H-indazole-4-carboxamide

C31H39N7O2 (541.3165074)

14-Benzoylneoline

[11-ethyl-8,16-dihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate

Asn Pro Arg Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

Asn Arg Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

Asn Arg Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

Pro Asn Arg Arg

(2S)-5-carbamimidamido-2-[(2S)-5-carbamimidamido-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]pentanoic acid

Pro Arg Asn Arg

(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-carbamoylpropanamido]pentanoic acid

Pro Arg Arg Asn

(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]-3-carbamoylpropanoic acid

Arg Asn Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

Arg Asn Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

Arg Pro Asn Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

Arg Pro Arg Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

Arg Arg Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

Arg Arg Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C25H43N5O8 (541.3111478000001)

LAPLE

Leu-Ala-Pro-Leu-Glu

PC(20:5/0:0)

3,5,9-Trioxa-4-phosphanonacosa-14,17,20,23,26-pentaen-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, [R-(all-Z)]-

LPC 20:5

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphocholine

[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-acetyloxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] pentanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] propanoate

lysoPC 20:5

LysoPC(20:5(5Z,8Z,11Z,14Z,17Z))

GSK343

1-Isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide

C31H39N7O2 (541.3165074)

lysophosphatidylcholine 20:5

A lysophosphatidylcholine in which the acyl group contains 20 carbons and 5 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.

lysophosphatidylcholine(0:0/20:5)

A 2-acyl-sn-glycero-3-phosphocholine in which the 2-acyl group contains 20 carbons and 5 double bonds.

1-icosapentaenoyl-sn-glycero-3-phosphocholine

A 1-acyl-sn-glycero-3-phosphocholine in which the 1-acyl group contains 20 carbons and 5 double bonds.

MePC(19:5)

MePC(8:1(1)_11:4)

PC(20:5)

PC(10:1(1)_10:4)

LPC 0:0/20:5

LPC 20:5/0:0

PC O-18:5/2:0

PC O-20:5

PC P-20:4

PC P-20:4 or PC O-20:5

ST 29:6;O5;Gly

ST 23:5;O2;HexNAc

ST 26:2;O4;Tau

C28H47NO7S (541.3073072)

(1s,2r,3r,4s,5r,6s,8r,9s,10s,13r,16s,17r,18s)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

{7-ethyl-2,11,12-trihydroxy-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-12-yl}methyl 3,4-dimethoxybenzoate

(1s,3s,4s,5s,7s,9s,15r,16s,17r)-3,4,7-trihydroxy-9,11-dimethyl-16-{[(2e)-2-methylbut-2-enoyl]oxy}-19-methylidene-11-azahexacyclo[12.3.2.0¹,¹³.0⁴,⁹.0⁵,¹².0⁵,¹⁷]nonadecan-15-yl (2e)-2-methylbut-2-enoate

(1s,3s,4s,5s,7s,9s,15r,16s,17r)-3,4,7-trihydroxy-9,11-dimethyl-16-{[(2e)-2-methylbut-2-enoyl]oxy}-19-methylidene-11-azahexacyclo[12.3.2.0¹,¹³.0⁴,⁹.0⁵,¹².0⁵,¹⁷]nonadecan-15-yl (2e)-2-methylbut-2-enoate

[(1r,2s,5r,8r,9r,10r,11s,12r,13s,15r,16r)-7-ethyl-2,11,12-trihydroxy-5-methyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-12-yl]methyl 3,4-dimethoxybenzoate

(1s,3s,4s,5s,7s,9s,14s,15r,16s,17r)-3,4,7-trihydroxy-9,11-dimethyl-16-{[(2e)-2-methylbut-2-enoyl]oxy}-19-methylidene-11-azahexacyclo[12.3.2.0¹,¹³.0⁴,⁹.0⁵,¹².0⁵,¹⁷]nonadecan-15-yl (2e)-2-methylbut-2-enoate

(1s,3s,4s,5s,7s,9s,14s,15r,16s,17r)-3,4,7-trihydroxy-9,11-dimethyl-16-{[(2e)-2-methylbut-2-enoyl]oxy}-19-methylidene-11-azahexacyclo[12.3.2.0¹,¹³.0⁴,⁹.0⁵,¹².0⁵,¹⁷]nonadecan-15-yl (2e)-2-methylbut-2-enoate

n-{5-[4-hydroxy-5-(8-hydroxy-2,5,9-trimethylpentadeca-2,4,9,12-tetraenoyl)-6-oxopyran-2-yl]hex-1-en-1-yl}methoxycarboximidic acid

n-[(1e)-5-{6-hydroxy-5-[(2e,4e,9z,13e)-8-hydroxy-2,5,9-trimethylpentadeca-2,4,9,13-tetraenoyl]-4-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid

n-[(1e)-5-{4-hydroxy-5-[(2e,4e,9z,12e)-8-hydroxy-2,5,9-trimethylpentadeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid

(3r)-3-[(2s)-1-[(3r,5e)-6-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}-3-hydroxy-4-(hydroxymethyl)-2-methylhex-5-enoyl]pyrrolidin-2-yl]-3-hydroxypropanimidic acid

(3r)-3-[(2s)-1-[(3r,5e)-6-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}-3-hydroxy-4-(hydroxymethyl)-2-methylhex-5-enoyl]pyrrolidin-2-yl]-3-hydroxypropanimidic acid

C26H43N3O9 (541.2999148)

(2s,3r,5s,8r,13s,17r)-11-ethyl-8,16-dihydroxy-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

n-[(1e,5r)-5-{4-hydroxy-5-[(2e,4e,8r,9z,12e)-8-hydroxy-2,5,9-trimethylpentadeca-2,4,9,12-tetraenoyl]-6-oxopyran-2-yl}hex-1-en-1-yl]methoxycarboximidic acid

11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate